AI assistant
Sending…
GlaxoSmithKline PLC — Director's Dealing 2017
May 2, 2017
5262_dirs_2017-05-02_d43ad7f7-3ba5-4205-99c1-c5cd685d573f.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 9177D
GlaxoSmithKline PLC
02 May 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
| 1. | Details of PDMR/person closely associated with them ('PCA') | ||||
| a) | Name | Ms C Thomas | |||
| b) | Position/status | SVP, Human Resources | |||
| c) | Initial notification/ amendment |
Initial Notification | |||
| 2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | GlaxoSmithKline plc | |||
| b) | LEI | 5493000HZTVUYLO1D793 | |||
| 3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
| a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 |
|||
| b) | Nature of the transaction | The exercise of a nil-cost option over Ordinary Shares granted on 20 March 2014 and, as previously announced, was adjusted for performance and vested on 20 March 2017 under the Company's 2009 Deferred Annual Bonus Plan- Matching Award associated with a post-tax bonus deferral. | |||
| c) | Price(s) and volume(s) |
Price(s) | Volume(s) | ||
| £0.0000 | 989 | ||||
| d) | Aggregated information | n/a single transaction | |||
| Aggregated volume Price | |||||
| e) | Date of the transaction | 2017-04-28 | |||
| f) | Place of the transaction | n/a |
| 1. | Details of PDMR/person closely associated with them ('PCA') | ||||
| a) | Name | Ms C Thomas | |||
| b) | Position/status | SVP, Human Resources | |||
| c) | Initial notification/ amendment |
Initial Notification | |||
| 2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | GlaxoSmithKline plc | |||
| b) | LEI | 5493000HZTVUYLO1D793 | |||
| 3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
| a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 |
|||
| b) | Nature of the transaction | The sale of Ordinary Shares to meet tax liabilities on a nil-cost option over Ordinary Shares exercised on 28 April 2017 under the Company's Deferred Annual Bonus Plan - Matching Award associated with a post-tax bonus deferral. | |||
| c) | Price(s) and volume(s) |
Price(s) | Volume(s) | ||
| £15.5450 | 467 | ||||
| d) | Aggregated information | n/a single transaction | |||
| Aggregated volume Price | |||||
| e) | Date of the transaction | 2017-04-28 | |||
| f) | Place of the transaction | London Stock Exchange (XLON) |
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLLLFBDEFBBBF
More from GlaxoSmithKline PLC
Report Publication Announcement
2026
May 22
Regulatory Filings
2026
May 22
Director's Dealing
2026
May 20
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 20
Director's Dealing
2026
May 19
Regulatory Filings
2026
May 19
Transaction in Own Shares
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18